Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Regenxbio (RGNX) Interest & Investment Income (2016 - 2025)

Regenxbio (RGNX) has 11 years of Interest & Investment Income data on record, last reported at $2.7 million in Q4 2025.

  • For Q4 2025, Interest & Investment Income fell 71.15% year-over-year to $2.7 million; the TTM value through Dec 2025 reached $12.2 million, down 34.62%, while the annual FY2025 figure was $12.2 million, 34.62% down from the prior year.
  • Interest & Investment Income reached $2.7 million in Q4 2025 per RGNX's latest filing, down from $3.6 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $9.5 million in Q4 2024 and bottomed at $311000.0 in Q4 2021.
  • Average Interest & Investment Income over 5 years is $2.7 million, with a median of $2.4 million recorded in 2023.
  • Peak YoY movement for Interest & Investment Income: plummeted 97.75% in 2021, then skyrocketed 551.45% in 2022.
  • A 5-year view of Interest & Investment Income shows it stood at $311000.0 in 2021, then surged by 551.45% to $2.0 million in 2022, then grew by 16.78% to $2.4 million in 2023, then skyrocketed by 302.2% to $9.5 million in 2024, then tumbled by 71.15% to $2.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Interest & Investment Income were $2.7 million in Q4 2025, $3.6 million in Q3 2025, and $3.4 million in Q2 2025.